首页> 美国卫生研究院文献>The Cochrane Database of Systematic Reviews >Perioperative administration of buffered versus non‐buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures
【2h】

Perioperative administration of buffered versus non‐buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures

机译:围手术期给予缓冲性和非缓冲性晶体静脉输液以改善成人手术后的结局

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

BackgroundPerioperative fluid strategies influence clinical outcomes following major surgery. Many intravenous fluid preparations are based on simple solutions, such as normal saline, that feature an electrolyte composition that differs from that of physiological plasma. Buffered fluids have a theoretical advantage of containing a substrate that acts to maintain the body’s acid‐base status ‐ typically a bicarbonate or a bicarbonate precursor such as maleate, gluconate, lactate, or acetate. Buffered fluids also provide additional electrolytes, including potassium, magnesium, and calcium, more closely matching the electrolyte balance of plasma. The putative benefits of buffered fluids have been compared with those of non‐buffered fluids in the context of clinical studies conducted during the perioperative period. This review was published in 2012, and was updated in 2017.
机译:背景围手术期液体策略影响大手术后的临床结果。许多静脉输液制剂均基于简单的溶液(例如生理盐水),其电解质成分不同于生理血浆。缓冲液在理论上具有优势,可以容纳可维持人体酸碱状态的底物-通常为碳酸氢盐或碳酸氢盐前体,例如马来酸盐,葡萄糖酸盐,乳酸盐或乙酸盐。缓冲液还提供其他电解质,包括钾,镁和钙,与血浆的电解质平衡更为接近。在围手术期进行的临床研究中,已将缓冲液与非缓冲液的假定益处进行了比较。该评价于2012年发布,并于2017年更新。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号